| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
|
Otterson, Gregory A
|
|
2004
|
44 |
2 |
p. 251-259
9 p.
|
artikel
|
| 2 |
Corrigendum to “Genetic susceptibility and dietary patterns in lung cancer”
|
Tsai, Ya-Yu
|
|
2004
|
44 |
2 |
p. 271-
1 p.
|
artikel
|
| 3 |
Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma
|
Davidson, Ben
|
|
2004
|
44 |
2 |
p. 159-165
7 p.
|
artikel
|
| 4 |
FDG-PET in staging lung cancer
|
Verhagen, A.F.T.
|
|
2004
|
44 |
2 |
p. 175-181
7 p.
|
artikel
|
| 5 |
Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma
|
Sanlioglu, Ahter D.
|
|
2004
|
44 |
2 |
p. 199-211
13 p.
|
artikel
|
| 6 |
IFC:paid ad
|
|
|
2004
|
44 |
2 |
p. IFC-
1 p.
|
artikel
|
| 7 |
Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer
|
Trojan, Andreas
|
|
2004
|
44 |
2 |
p. 143-147
5 p.
|
artikel
|
| 8 |
Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines
|
Kuhn, Hartmut
|
|
2004
|
44 |
2 |
p. 167-174
8 p.
|
artikel
|
| 9 |
Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location
|
Kotoulas, Christophoros S.
|
|
2004
|
44 |
2 |
p. 183-191
9 p.
|
artikel
|
| 10 |
Is NSE truly a useful marker in NSCLC?
|
Ishikawa, Hiroichi
|
|
2004
|
44 |
2 |
p. 267-
1 p.
|
artikel
|
| 11 |
Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy
|
Wirth, Lori J.
|
|
2004
|
44 |
2 |
p. 213-220
8 p.
|
artikel
|
| 12 |
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study
|
Jänne, Pasi A.
|
|
2004
|
44 |
2 |
p. 221-230
10 p.
|
artikel
|
| 13 |
Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer
|
Stewart, David J
|
|
2004
|
44 |
2 |
p. 241-249
9 p.
|
artikel
|
| 14 |
Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer
|
Ceresoli, Giovanni Luca
|
|
2004
|
44 |
2 |
p. 231-239
9 p.
|
artikel
|
| 15 |
pre iii
|
|
|
2004
|
44 |
2 |
p. iii-
1 p.
|
artikel
|
| 16 |
pre v
|
|
|
2004
|
44 |
2 |
p. v-
1 p.
|
artikel
|
| 17 |
pre vi
|
|
|
2004
|
44 |
2 |
p. vi-
1 p.
|
artikel
|
| 18 |
pre vii
|
|
|
2004
|
44 |
2 |
p. vii-
1 p.
|
artikel
|
| 19 |
Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors
|
Bazhin, Alexandr V
|
|
2004
|
44 |
2 |
p. 193-198
6 p.
|
artikel
|
| 20 |
Reply to “Is NSE truly a useful marker in NSCLC?”
|
Ferrigno, Domenico
|
|
2004
|
44 |
2 |
p. 269-
1 p.
|
artikel
|
| 21 |
Secondary leukaemia after cure for locally advanced NSCLC
|
Griesinger, Frank
|
|
2004
|
44 |
2 |
p. 261-265
5 p.
|
artikel
|
| 22 |
The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms
|
Chang, Yih-Leong
|
|
2004
|
44 |
2 |
p. 149-157
9 p.
|
artikel
|
Tijdschrift beschrijving